We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-5.07%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.24B
AUM Growth
-$48.8M
Cap. Flow
-$14.9M
Cap. Flow %
-0.46%
Top 10 Hldgs %
35.11%
Holding
101
New
30
Increased
21
Reduced
24
Closed
20

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$134M
2
HCA icon
HCA Healthcare
HCA
+$114M
3
AAPL icon
Apple
AAPL
+$108M
4
ELV icon
Elevance Health
ELV
+$69.3M
5
GILD icon
Gilead Sciences
GILD
+$69.3M

Top Sells

Rank Stock Value
1
AER icon
AerCap
AER
+$126M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$122M
3
SCHW
Charles Schwab
SCHW
+$91.5M
4
WBA
Walgreens Boots Alliance
WBA
+$85.3M
5
TXT icon
Textron
TXT
+$66.1M

Sector Composition

Rank Sector Weight
1 Healthcare 45.12%
2 Technology 13.88%
3 Financials 7.38%
4 Communication Services 6.63%
5 Consumer Discretionary 3.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCA icon
1
HCA Healthcare
HCA
$82.8B
$159M 4.91%
2,038,188
+1,636,371
+407% +$114M
ABBV icon
2
AbbVie
ABBV
$452B
$137M 4.22%
+2,396,328
New +$134M
AAPL icon
3
Apple
AAPL
$4.81T
$118M 3.65%
+4,339,012
New +$108M
BMY icon
4
Bristol-Myers Squibb
BMY
$124B
$118M 3.65%
1,850,371
-1,003,469
-35% -$63.3M
BMY icon
5
CALL
Bristol-Myers Squibb
BMY
$124B
$117M 3.6%
1,828,000
+950,900
+108% +$60M
OEF icon
6
CALL
iShares S&P 100 ETF
OEF
$20.2B
$111M 3.42%
+424,700
New +$37M
WBA
7
DELISTED
Walgreens Boots Alliance
WBA
$101M 3.12%
1,199,318
-1,067,878
-47% -$85.3M
JAZZ icon
8
Jazz Pharmaceuticals
JAZZ
$15.3B
$99.8M 3.08%
764,384
+252,534
+49% +$31.4M
LRCX icon
9
Lam Research
LRCX
$403B
$90.7M 2.8%
10,986,460
+2,938,130
+37% +$21.4M
ALDR
10
DELISTED
Alder Biopharmaceuticals
ALDR
$86.8M 2.68%
3,542,647
+1,652,617
+87% +$38.3M
EW icon
11
Edwards Lifesciences
EW
$48.9B
$85.5M 2.64%
2,907,021
-615,273
-17% -$17M
AGN
12
DELISTED
Allergan plc
AGN
$84.2M 2.6%
314,106
-178,353
-36% -$51.1M
PANW icon
13
Palo Alto Networks
PANW
$279B
$81.1M 2.5%
2,983,572
-1,929,540
-39% -$47.4M
GOOGL icon
14
Alphabet (Google) Class A
GOOGL
$4.24T
$77.9M 2.4%
2,042,300
-708,420
-26% -$26.1M
GILD icon
15
Gilead Sciences
GILD
$162B
$76.7M 2.37%
835,032
+768,845
+1,162% +$69.3M
AMZN icon
16
Amazon
AMZN
$2.66T
$75.8M 2.34%
2,553,280
-387,920
-13% -$11M
MSFT icon
17
Microsoft
MSFT
$2.95T
$75.5M 2.33%
1,367,103
+874,960
+178% +$45.9M
ELV icon
18
Elevance Health
ELV
$82.9B
$72.1M 2.22%
+518,909
New +$69.3M
MDCO
19
DELISTED
Medicines Co
MDCO
$70.7M 2.18%
2,226,207
+159,660
+8% +$5.21M
UHS icon
20
Universal Health Services
UHS
$9.08B
$67.5M 2.08%
541,456
-32,449
-6% -$3.65M
BLK icon
21
Blackrock
BLK
$161B
$64.4M 1.99%
189,158
+59,958
+46% +$19M
HRTX icon
22
Heron Therapeutics
HRTX
$90.3M
$58.4M 1.8%
3,073,470
+296,006
+11% +$5.84M
PYPL icon
23
PayPal
PYPL
$49.3B
$57.4M 1.77%
+1,487,245
New +$53.7M
ABBV icon
24
CALL
AbbVie
ABBV
$452B
$53.2M 1.64%
+930,600
New +$51.9M
VMC icon
25
Vulcan Materials
VMC
$36.4B
$52.1M 1.61%
493,071
-530,214
-52% -$50.2M
1
2 3 4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.1B AUM 8.96% 1-Year Est. Return
AWP
Abacus Wealth Partners Santa Monica, California $1.1B AUM 14.74% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

PFM Health Sciences's Q1 2016 Portfolio in Review

As of Q1 2016, PFM Health Sciences held 101 positions worth $3.24B, down 1.5% from $3.29B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

PFM Health Sciences's Q1 2016 filing shows 30 new, 21 increased, 24 reduced and 20 closed positions. Its largest new stake was AbbVie: 2,396,328 shares worth $137M. The largest sale was AerCap, an estimated $126M.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 48% a quarter earlier, followed by Technology and Financials.

  • PFM Health Sciences's largest Q1 2016 buy was AbbVie: 2,396,328 shares worth $137M.
  • PFM Health Sciences added most to HCA Healthcare in Q1 2016, an estimated $114M increase.
  • PFM Health Sciences's biggest Q1 2016 reduction was Walgreens Boots Alliance, cutting an estimated $85.3M.
  • PFM Health Sciences fully exited AerCap in Q1 2016, selling an estimated $126M.
  • PFM Health Sciences's ten largest holdings make up 35% of its $3.24B portfolio in Q1 2016.
  • PFM Health Sciences opened 30 new positions and closed 20 in Q1 2016.
  • PFM Health Sciences's portfolio value fell 1.5% quarter-over-quarter to $3.24B.

Based on PFM Health Sciences's 13F filing for Q1 2016, filed 16 May 2016.